We are live on
!
Find out more
MBT
Montecito Bank & Trust Portfolio holdings
AUM
$668M
1-Year Est. Return
24.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.86%
1 Year Est. Return
+24.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$278M
AUM Growth
+$4.23M
(+1.5%)
Cap. Flow
-$2.52M
Cap. Flow
% of AUM
-0.91%
Top 10 Holdings %
Top 10 Hldgs %
48.17%
Holding
203
New
17
Increased
44
Reduced
94
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR MSCI ACWI ex-US ETF
CWI
|
+$4.73M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$2.58M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$2.29M |
| 4 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$2.26M |
| 5 |
Alerian MLP ETF
AMLP
|
+$1.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CytomX Therapeutics
CTMX
|
+$1.78M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.22M |
| 3 |
Vanguard Mid-Cap ETF
VO
|
+$862K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$804K |
| 5 |
NVIDIA
NVDA
|
+$763K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 5.24% |
| 2 | Healthcare | 5.22% |
| 3 | Technology | 3.58% |
| 4 | Industrials | 3.32% |
| 5 | Energy | 3.03% |
Similar funds
LIA
AGM
IACCIA
TAP
CWP
AO
PFA
SP
Montecito Bank & Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Montecito Bank & Trust held 203 positions worth $278M, up 1.5% from $274M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Montecito Bank & Trust's Q2 2017 filing shows 17 new, 44 increased, 94 reduced and 30 closed positions. Its largest new stake was WisdomTree Europe Hedged Equity Fund: 69,846 shares worth $2.18M. The largest sale was CytomX Therapeutics, an estimated $1.78M.
By sector, the portfolio is most concentrated in Consumer Staples at 5.2% of assets, up from 5.1% a quarter earlier, followed by Healthcare and Technology.
- Montecito Bank & Trust's largest Q2 2017 buy was WisdomTree Europe Hedged Equity Fund: 69,846 shares worth $2.18M.
- Montecito Bank & Trust added most to State Street SPDR MSCI ACWI ex-US ETF in Q2 2017, an estimated $4.73M increase.
- Montecito Bank & Trust's biggest Q2 2017 reduction was CytomX Therapeutics, cutting an estimated $1.78M.
- Montecito Bank & Trust fully exited Vanguard FTSE Emerging Markets ETF in Q2 2017, selling an estimated $516K.
- Montecito Bank & Trust's ten largest holdings make up 48% of its $278M portfolio in Q2 2017.
- Montecito Bank & Trust opened 17 new positions and closed 30 in Q2 2017.
- Montecito Bank & Trust's portfolio value rose 1.5% quarter-over-quarter to $278M.
Based on Montecito Bank & Trust's 13F filing for Q2 2017, filed 26 Jul 2017.